Study of IBI3009 alone or in combination with other therapies for extensive-stage small cell lung cancer
CIBI3009A101
Phase 2 other active
Quick answer
Study of IBI3009 alone or in combination with other therapies for extensive-stage small cell lung cancer for Extensive-Stage Small Cell Lung Cancer is a Phase 2 program (other) at Vita (Europe) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vita (Europe) Limited
- Indication
- Extensive-Stage Small Cell Lung Cancer
- Phase
- Phase 2
- Modality
- other
- Status
- active